ArticleWorld journal of clinical cases2025
Life-course management of gestational diabetes mellitus: A narrative review.
Article in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Association between Lipid Profile, Anthropometric Parameters, and Gestational Diabetes Mellitus: A cross-sectional analysis of NHANES 2015-2023.Pakistan journal of medical sciences · 2026Article
- Gestational diabetes: from pathogenesis to therapeutic intervention.Diabetology & metabolic syndrome · 2026Review
- Special Issue "Molecular Insight into Gestational Diabetes Mellitus".International journal of molecular sciences · 2026Article
- Pregnant Women With Gestational Diabetes Mellitus and High Consumption of Tryptophan-Rich Foods Show Increased Levels of 6-Sulfatoxymelatonin in Urine.Journal of pregnancy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGestational diabetes mellitus (GDM) has emerged as a global public health challenge, fueled by increasing maternal age, rising obesity rates, and lifestyle shifts. It is linked to substantial short- and long-term health risks for both mothers and their offspring, offering a critical opportunity for intergenerational prevention of metabolic disorders.
aimTo synthesize current evidence on the pathophysiology, diagnosis, management, complications, and individualized treatment strategies of GDM.
methodsWe conducted a narrative review in accordance with PRISMA guidelines. PubMed, Scopus, Web of Science, and EMBASE were searched for English-language articles (2017-2025) using terms such as "GDM", "pregnancy", "insulin resistance", and "maternal outcomes". After removing duplicates, 512 records were screened; 102 full texts were assessed for eligibility, and 55 studies were included based on methodological quality, clinical relevance, and alignment with the review objectives.
resultsGDM results from a complex interplay among progressive insulin resistance, β-cell dysfunction, immune dysregulation, and placental inflammation. Emerging evidence indicates that hyperglycemia before formal diagnosis can impair fetal programming
conclusionGDM requires precision-based, life-course care. Future priorities include early risk detection, biomarker validation, unified diagnosis, and culturally sensitive interventions to improve maternal-child outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.